PS

Poul Sørensen

Serial Biotech Innovator and Life Science Executive

Paris, Île-de-France

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Paris, France

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

R&D
Research
Biopharmaceuticals
Biotechnology
Drug Discovery
Pharmaceuticals
Molecular Biology
Immunology
Strategic Planning
Antibody engineering
Innovation Management
Inflammation
Allergy
Psoriasis
Dermatology
Antibodies
Biomarkers
Translational Medicine
Vaccines
Autoimmune

Education

Lists including Poul

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

A
ARGOBIO

2022

  • Partner and Entrepreneur-in-Residence

    2022

AT
Allero Therapeutics

2016

  • Co-founder & Chief Scientific Officer

    2016

AU
Aarhus University

2015

  • Honorary Professor of Biomedicine

    2015

C
Cenexum

2022

  • Co-founder and Board Member

    2022

VP
Ventac Partners

2018 - 2022

  • Partner

    2018 - 2022

Medday Pharmaceuticals

2019 - 2020

  • Global Head of Corporate Strategy & Business Development

    2019 - 2020

SG
Stallergenes Greer

2012 - 2017

  • Senior Vice President, Global Head of Strategic Development

    2012 - 2017

AA
ALK Abelló

2008 - 2012

  • Vice President, Global Research

    2008 - 2012

BR
Biotech Research & Innovation Centre (BRIC), University of Copenhagen

2005 - 2011

  • Member Board Of Directors

    2005 - 2011

LP
LEO Pharma

2005 - 2008

  • Research Director

    2005 - 2008